XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Inventories (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Inventory Disclosure [Abstract] |
Schedule of Inventory, Current | At March 31, 2024 and December 31, 2023, the Company's net inventories consisted of the following:
|  | March 31, 2024 |  | December 31, 2023
Raw materials and work in process |  | $ | 12,772,140 |  |  | $ | 12,619,092 |
Consigned inventory |  | 231,264 |  |  | 149,701 |
Finished goods |  | 4,240,018 |  |  | 4,645,098 |
Total inventories |  | 17,243,422 |  |  | 17,413,891 |
less non-current inventories |  | (12,915,896) |  |  | (12,804,529) |
Total inventories classified as current |  | $ | 4,327,526 |  |  | $ | 4,609,362 |
Schedule of Inventory, Noncurrent | At March 31, 2024 and December 31, 2023, the Company's non-current inventories consisted of the following:
|  | March 31, 2024 |  | December 31, 2023
Vibativ Raw Materials |  | $ | 6,611,426 |  |  | $ | 6,611,426 |
Kristalose Raw Materials |  | 3,213,387 |  |  | 3,263,516 |
Vaprisol Conivaptan Raw Materials |  | 1,173,442 |  |  | 1,170,641 |
Sancuso Raw Materials |  | 578,804 |  |  | 574,502 |
Caldolor Raw Materials |  | 31,489 |  |  | — |
Acetadote Raw Materials |  | 25,048 |  |  | 33,678 |
Study Drug Ifetroban Raw Materials |  | 203,383 |  |  | 203,383 |
Vibativ Finished Goods |  | 955,969 |  |  | 810,454 |
Caldolor Finished Goods |  | 53,326 |  |  | 67,307 |
Omeclamox |  | 69,622 |  |  | 69,622 |
Total inventories classified as non-current |  | $ | 12,915,896 |  | 12915896 | $ | 12,804,529 |

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1 + Details
Name: | us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle including inventoried costs relating to long-term contracts or programs. + References No definition available. + Details
Name: | us-gaap_ScheduleOfInventoryNoncurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration